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Abstract: Glycolipids were extracted from the red alga Osmundaria obtusiloba   
from  Southeastern Brazilian coast. The acetone insoluble material was extracted with 
chloroform/methanol and the lipids, enriched in glycolipids, were fractionated on a silica 
gel column eluted with chloroform, acetone and then methanol. Three major orcinol-positive 
bands were found in the acetone and methanol fractions, being detected by thin layer 
chromatography. The structures of the corresponding glycolipids were elucidated by   
ESI-MS and 
1H/
13C NMR analysis, on the basis of their tandem-MS behavior and HSQC, 
TOCSY fingerprints. For the first time, the structure of sulfoquinovosyldiacylglycerol from 
the red alga Osmundaria obtusiloba was characterized. This molecule exhibited potent 
antiviral activity against HSV-1 and HSV-2 with EC50 values of 42 µg/mL to HSV-1 and 
12 µg/mL to HSV-2, respectively. Two other glycolipids, mono- and digalactosyldiacylglycerol, 
were also found in the alga, being characterized by ESI-MS/MS. The structural elucidation 
of algae glycolipids is a first step for a better understanding of the relation between these 
structures and their biological activities. 
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1. Introduction 
Glycolipids constitute an important class of membrane lipids that are synthesized by both 
prokaryotic and eukaryotic organisms. Major glycolipids such as monogalactosyldiacylglycerol 
(MGDG), digalactosyldiacylglycerol (DGDG) and sulfoquinovosyldiacylglycerol (SQDG), along with 
phospholipids were isolated from red, green and brown algae, such as, for example, Anfeltia 
tobuchiensis  (Rhodophyta),  Ulva fenestrate (Chlorophyta),  Laminaria japonica (Chlorophyta), 
Sargassum pallidum (Phaeophyta) [1], Sargassum thunbergii (Phaeophyta) [2], Exophlyllum wentii 
(Rhodophyta) [3] and Chondria armata (Rhodophyta) [4], as well as in simbiotic organisms having 
mycroalgae [5,6]. These lipids are reported to exhibit diverse biological functions [7,8]. MGDGs from 
the green alga Chlorella vulgaris, exhibit anti-tumor effect [9]. SQDG from the red alga Gigartina 
tenella inhibits the eukaryotic DNA polymerase and HIV-reverse transcriptase type 1 [10] and SQDG 
identified in Porphyridium purpureum and other microalgae presents antivirus activity [11]. Most 
studies show the antiviral activity of sulfated polysaccharides from marine alga [12–18] but studies 
using sulfoglycolipids have received less attention [19–22]. Due to economic importance of algae, as a 
rich source of bioactive compounds with potential biomedicinal interest, there is an increasing need for 
improved techniques for isolation pure compounds. In our search for potentially useful bioactive 
molecules of marine origin, we have isolated and identified the glycolipids from the red alga 
Osmundaria obtusiloba from Southeastern Brazilian coast using electrospray ionization tandem mass 
spectrometry (ESI-MS/MS) complemented with NMR. In the present study we also evaluated the 
inhibitory activity of sulfoquinovosyldiacylglycerol from the red marine alga Osmundaria obtusiloba 
on the herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2). Herpes simplex viruses are 
responsible for a broad range of human infectious diseases. Despite acyclovir is the drug of choice for 
treating the HSV infections, new antiviral agents exhibiting different mechanisms of action is urgently 
needed, mainly due to the high number of acyclovir-resistant strains [23]. 
2. Results and Discussion 
2.1. Lipid Fractionation 
Osmundaria obtusiloba was treated with acetone and kept overnight at −14 °C. The acetone 
insoluble material was successively extracted with chloroform/methanol 2:1 and 1:2 (v/v) at room 
temperature [22,24]. The combined extracts were concentrated in vacuo and the crude lipid fraction 
was partitioned according to Folch and coworkers [25]. The lipids recovered from the Folch lower 
layer, enriched in glycolipids, were fractionated on a silica gel column, eluted with chloroform, 
acetone and then methanol. Figure 1 shows the steps of purification. 
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Figure 1. Overview of the strategy used for purification of glycolipids from Osmundaria 
obtusiloba. Purified or partially purified fractions are usually resolved by TLC and 
visualized with iodine and orcinol-H2SO4.  
 
Orcinol reactive bands were detected on TLC from fractions eluted with acetone and methanol.  
A single main spot orcinol-positive was detected in the acetone fraction (F-Ac), whereas at least three 
positive spots could be visualized on TLC of methanol fraction (F-MeOH). This enriched glycolipid 
fraction was then purified by a second silica gel chromatography, eluted by a gradient of CHCl3/MeOH, 
increasing the solvent polarity, giving rise to fractions F1–F5 (Figure 1). These fractions were 
analyzed on TLC plates developed with CHCl3:MeOH:2M NH4OH (40:10:1 v/v/v) and visualized 
through iodine vapor and by spraying the plates with orcinol-sulfuric acid [26]. The partially purified 
glycolipids were then analyzed by ESI-MS in the positive and negative ionization modes. 
2.2. Mass Spectrometry of Neutral Glycolipids 
In order to improve the positive ion detection of neutral lipids, Li
+ (LiCl) was added in the sample 
solvent, giving the molecules as lithiated ions. The acetone fraction (F-Ac) gave in MS
1 an ion with 
m/z 777 [M + Li]
+. This was fragmented by CID-MS, giving rise to characteristic spectrum of neutral 
glyceroglycolipids, with a fragment-ion at m/z 615, consistent with a monosaccharide residue loss, 
those at m/z 521 and 481 were consistent with loss of a palmitc acid (C16:0) and an unusual nonadecenoic 
(C19:1) acid, respectively. The fragment-ions from glycan moiety appeared at m/z 227, 187 and 169 
(Figure 2A), thus being consistent with the fragmentation partner of a monogalactosyldiacylglycerol 
(MGDG) [27]. Mar. Drugs 2012, 10 921 
 
Figure 2. ( A) Tandem-MS and fragmentation profile obtained from lithiated 
monogalactosyldiacylglycerol, precursor ion at m/z 777, from acetone Fraction (F-Ac);   
(B) from lithiated digalactosyldiacylglycerol, precursor ion at m/z 939, from Fraction 5. 
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Fraction 5, an orcinol-positive sub-fraction from F-MeOH, was also analyzed in positive ion mode 
assisted by Li
+, giving a main ion at m/z 939. These were fragmented giving rise to fragments at  
m/z 777 and a small m/z 615, consistent with loss a monosaccharide and a disaccharide, respectively. 
The fragments at m/z 683 and 643 were consistent with loss of a palmitic and a nonadecenoic acid, 
respectively. The fragments at m/z 389, 331, 187 and 169 confirmed the presence of a disaccharide, 
being this glycolipid consistent with a digalactosyldiacylglycerol (DGDG) [27,28]. Other fragments 
are shown in Figure 2B. 
2.3. Mass Spectrometry of Sulfolipids  
Fraction 1, a sub-fraction from F-MeOH, gave two positive spots for carbohydrate with lower Rf 
values. Furthermore, the spectrum obtained in negative MS
1 exhibited two main deprotonated ions 
with m/z 555 and 765 [M − H]
− (Figure 3). 
Figure 3. Spectrum from MS
1 obtained in negative ionization mode from Fraction 1. The 
ion at m/z 555 is compatible with the structure of a sulfoquinovosylmonoacylglycerol, 
whereas the one at m/z 765, with sulfoquinovosyldiacylglycerol. 
 
The distribution of isotopologues was 10:4:1.5 (for m/z 555, 556 and 557, respectively) and 10:5:2 
(for m/z 765, 766 and 767). The high intensity of the heavy isotopologues at m/z 557 and 767 is an 
indicative for the presence of a sulfur element in the molecules [29], occurring because of the presence 
of >4% of the heavy isotope (
34S). In lipid fractions from vegetable sources, the presence of sulfur 
element added to positive result for carbohydrate strongly suggests the presence of sulfolipids, such as 
sulfoquinovosyldiacylglycerol (SQDG), a lipid associated with phototrophic organisms [30,31]. 
In order to confirm the structures, the ions at m/z 555 and 765 were fragmented by the second stage 
tandem-MS. The results were consistent with the structure of the sulfoquinovosylmonoacylglycerol 
(SQMG-m/z 555) with a palmitic acid (C16:0), as indicated by the presence of fragments at m/z 299, 
243, 225, 165, 153, 95 and 81, whereas the ion at m/z 765 gave fragments at m/z 537 (M–C14:0),  
509 (M–C16:0), 225, 165, 153, 95 and 81, as indicated in the fragmentation pathway (Figure 4), being Mar. Drugs 2012, 10 923 
 
consistent with the SQDG structure, esterified by myristic and palmitic acids. Structures of 
sulfonoglycolipids are frequently studied by tandem-MS, and the fragments at m/z 225, 165, 153, 95 
and 81can be considered as diagnostics for 6-deoxy-6-sulfono-hexosyl residue [6,28,32,33].  
Figure 4. Tandem-MS fingerprint and a proposed fragmentation pathway of 
sulfoquinovosyldiacylglycerol, precursor ion at m/z 765, under collision induced 
dissociation-mass spectrometry. 
 
The lower abundant ions in the MS
1 spectrum occurred due to other fatty acids combination,   
such as that one at m/z 793, usually associated with sulfoquinovosyl-dipalmitoylglycerol or   
myristoyl-steaorylglycerol. Although the structures had been well characterized by MS
2, the absolute 
hydroxyl configuration could not be determined by mass spectrometry. Since SQDG (m/z 765) was the 
predominant glycolipid found in Fraction 2, this fraction was used for NMR experiments, such as 
COSY, TOCSY and HSQC and biological activity as well. 
2.4. NMR Spectroscopy of Sulfolipids 
The structure of the sulfoglycolipid present in fraction 2, was confirmed by 
1H and 
13C NMR 
analysis, based on HSQC and TOCSY fingerprints [5,6]. The chemical shift map was obtained by 
HSQC and discussed as follows. The HSQC spectrum of glycolipid contained aliphatic signals from 
δ 22.8 to 34.6 with predominant CH2 signals at δ 29.9 and CH3 at δ 14.1. The spectrum suggests the 
presence of exclusively saturated fatty acids, since no double bond signals were observed at δ 122.0 to 
133.0 [6,33] and confirms the previous ESI-MS/MS results. The signals of 
1H/
13C-HSQC and   Mar. Drugs 2012, 10 924 
 
1H/
1H-TOCSY from glycerol were observed at δ 4.009, 3.570/66.4; 5.280/70.9; and 4.417, 4.159/63.5, 
arising from C-1, C-2, and C-3, respectively (Figure 5A,B). 
Figure 5. (A) Partial 2D 
1H/
13C-HSQC fingerprint spectrum of sulfoquinovosyldiacylglycerol 
in fraction 1, showing the polar region of lipid; (B) Partial 2D 
1H/
1H-TOCSY spectrum, 
showing the fingerprint region containing the monosaccharide ring connectivity and 
glycerol moiety of the sulfonoglycolipid. 
 
On the 
1H/
13C-HSQC experiment, the anomeric region contained a single signal at δ 4.770/99.2, 
consistent with α-quinovopyranosyl group. Also, other key 
1H/
13C-HSQC signals were found at 
δ 3.267, 2.990/53.5. The presence of doublets of CH2 signals in a high-field region is characteristic of  
S-substituted C-6, typical of 6-sulfo-α-quinovopyranosyl unit [5,6]. In addition, the total hydroxyl 
connectivity observed in 
1H/
1H-TOCSY experiment (Figure 5B) confirmed the hydroxyl configuration 
of a 6-deoxy-α-glucopyranoyl (α-quinovosyl) unit. These results and those from mass spectrometry Mar. Drugs 2012, 10 925 
 
were very similar to previous findings for sulfonoglycolipids [4–7,34–36], confirming the lipid identity 
as 1,2-di-O-acyl-3-O-(6-deoxy-6-sulfo-α-D-glucopyranosyl)-sn-glycerol (SQDG). 
2.5. Antiviral Activity 
In a previous study from our group, the antiviral activity of the crude acetone and methanol 
fractions from a lipid extract of O. obtusiloba was evaluated and the results have demonstrated that 
both fractions had potent inhibitory activity against HSV-1 (herpes simplex virus type 1) and present 
low toxicity for cell cultures [22]. A better activity was found in the crude methanol fraction. In order 
to find out which compounds are responsible for this activity, a purified sulfoglycolipid fraction 
(Fraction 2) was obtained in the present work and the antiviral activity against HSV-1 and HSV-2 
(herpes simplex virus type 2) was measured (Table 1). 
Table 1. Cytotoxicity and antiviral activity of fraction 2 from Osmundaria obtusiloba  
and acyclovir. 
     HSV-1 HSV-2 
Compounds MNTC 
(µg/mL) 
CC50 
(µg/mL) 
PI EC50 
(µg/mL) 
SI PI EC50 
(µg/mL) 
SI 
Fraction 2 O. obtusiloba 50  72  75 42  1.7  96 12  6.0 
Acyclovir 200  >200  99  0.8  >250  99  1.38  >145 
HSV-1, herpes simplex virus type 1; HSV-2, herpes simplex virus type 2; MNTC, maximum   
non-toxic concentration; CC50, 50% cytotoxic concentration; PI, percentage of inhibition; EC50, effective 
concentration to reduce virus titers by 50%; SI, selectivity index. Acyclovir, standard compound. 
Our results showed a reduction in the antiviral activity of the purified glycolipid (75%) when 
compared with the crude methanol fraction (99.5%) [22]. The somewhat higher activity of the crude 
methanol fraction relative to the purified fraction 2 occurred, presumably, as a result of the absence of 
other polar lipids in this fraction , such as MGDG and DGDG, which can trigger a synergic effect. 
These results suggest the importance of both glycolipids (glycoglycerolipids and sulfoglycolipids) in 
the antiviral activity. The anti-HSV activity of glycolipids extracted from seaweed has been 
demonstrated [19–22]. El-Baroty and coworkers showed that glycolipid isolated from the brown alga 
Dilophys fasciola was able to block the viral infectivity by interacting with HSV-1 glycoprotein [22]. 
Studies will be conducted to determine the mechanism of action of sulfoglycolipid from O. obtusiloba. 
DGDG and SQDG from O. obtusiloba identified in this present work have been previously detected in 
other red algae Hypnea musciformis, Porphyra acanthophora, Pterocladiella capillacea, the brown 
alga  Dictyota menstrualis and D. cervicomis and in the green alga Caulerpa racemosa [22], 
confirming that these glycolipids are conserved molecules in green, red and brown algae isolated from 
the Southeastern Brazilian coast [22]. 
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3. Experimental Section 
3.1. Biological Material 
Osmundaria obtusiloba (C. Agardh) R. E. Norris (Rhodophyta-Fam. Rhodomelaceae) was collected 
at Praia Rasa, (22°44′3.15″S, 41°57′30.15″O), located at the city of Buzios, Rio de Janeiro, Brazil. The 
seaweed was washed with local sea water and separated from sediments, epiphytes and other 
associated organisms. 
3.2. Extraction and Fractionation of Lipids 
Osmundaria obtusiloba was treated with acetone and kept overnight at −14 °C. The acetone 
insoluble material was successively extracted at room temperature with chloroform/methanol 2:1 and 
1:2 (v/v). Extracts were combined, dried and the crude lipid extract was partitioned according to Folch 
and coworkers [25]. The lipids recovered from the Folch lower phase were fractionated on a silica  
gel column eluted with cloroform, acetone and then methanol. The methanol fraction containing   
the glycolipids was further purified on a silica gel column, which was sequentially eluted with 
chloroform/methanol with increasing concentrations of methanol (95:5, 90:10, 80:20, 70:30, 50:50, v/v) 
and finally with 100% methanol. Fractions eluted with chloroform/methanol 70:30 and 50:50 (v/v) 
yielded partially purified glycolipid fractions F1 to F5. These fractions were analysed by TLC, 
developed with CHCl3:CH3OH:2M NH4OH (40:10:1 v/v/v) and the spots visualized with iodine and 
by spraying with orcinol/H2SO4 [26]. Fraction 2, was further purified by preparative TLC, yielding a 
purified glycolipid fraction. 
3.3. Mass Spectrometry  
The MS analysis was carried out in an electrospray ionization mass spectrometry (ESI-MS), model 
Quattro-LC (Waters) with a triple-quadrupole mass analyzer, operating at atmospheric pressure 
ionization (API), assisted by a syringe pump (KDScientific) for sample infusion. Nitrogen was used as 
nebulizing and desovation gas and the ionization energies were 50 V on the cone and 2 kV on the 
capillary, operating in the negative ionization mode or 80 V (cone) and 2.5 kV (capillary) when 
operating in the positive ionization mode. The second stage tandem-MS was obtained by collision 
induced dissociation mass spectrometry (CID-MS) using argon as collision gas and collision energies 
ranging between 35–60 eV. The samples were prepared in MeOH at 1 mg/mL, then diluted to   
0.1 mg/mL in MeOH-H2O (7:3, v/v) containing 1 mM LiCl, for the positive ion detection, and direct 
infused into ESI source, at a flow rate of 10 µL/min. 
3.4. Nuclear Magnetic Resonance 
The glycolipid component of F2 was deuterium exchanged by repeated dissolution in MeOD–D2O 
(2:1 v/v) and freeze-drying. The spectra were obtained from solutions of MeOD–CDCl3 (1:1) at 30 °C, 
using TMS (tetramethylsilane) as reference standard (δ = 0). All spectra were obtained with a Bruker 
400 MHz AVANCE III NMR spectrometer with a 5 mm inverse gradient probe. 2D-NMR 
experiments were carried out using HSQC, COSY and TOCSY. The experiments were recorded for Mar. Drugs 2012, 10 927 
 
quadrature detection in the indirect dimension, edited-HSQC spectra were acquired using 128 scans 
per series of 1 K × 256 W data points with zero filling in F1 (4 K) prior to Fourier transformation [37]. 
3.5. Cells and Viruses  
Vero cells (African green monkey kidney) were grown in Eagle’s minimum essential medium 
(Eagle-MEM) and supplemented with 10% (v/v) fetal bovine serum, glutamine (2 mM), garamycin  
(50 µg/mL), fungizone (amphotericin B) (2.5 µg/mL), NaHCO3 (0.25%) and HEPES (10 mM). HSV-1 
was isolated from a typical lip lesion and HSV-2 from a typical genital lesion in the Virology 
Department of the Federal University of Rio de Janeiro (UFRJ), Brazil. Viruses were typed by 
polymerase chain reaction (PCR) using specific primers for identification [38]. 
3.6. Cytotoxicity Assay 
The cytotoxicity of glycolipids was performed by incubating Vero (African green monkey   
kidney cell) cell line monolayers cultivated in 96-well microplates with two-fold serial dilutions   
(200–3.1 µg/mL) of the SQDG (F-2) for 48 h at 37 °C in a 5% CO2 atmosphere. Cellular viability was 
evaluated by the neutral red dye-uptake method [39]. The 50% cytotoxic concentration (CC50) was 
deﬁned as the SQDG concentration which caused a 50% reduction in the number of viable cells. 
3.7. Antiviral Activity Assay 
The antiviral activity of SQDG and acyclovir was evaluated by the titer reduction. The virus titers 
were calculated using the Reed and Muench statistical method [40] and expressed as 50% tissue 
culture infective dose (TCID50) per mL. Vero cell monolayers were treated with the SQDG and 
acyclovir at the MNTC and 100 TCID50/mL of HSV-1 or HSV-2 suspensions were added to treated 
and untreated cell cultures and incubated at 37 °C for 48 h in a 5% CO2 atmosphere. After incubation, 
the supernatant was collected and virus titers in treated and untreated cells were determined. The 
antiviral activity was expressed as percentage of inhibition (PI) [41] using antilogarithmic TCID50 
values as follows: PI = [1 − (antilogarithmic test value/antilogarithmic control value)] × 100. The  
dose-response curve was established starting from the MNTC (50–0.78 µg/mL to SQDG and   
200–0.2 µg/mL to acyclovir) and the 50% effective concentration (EC50) was defined as the 
concentration required for 50% protection against virus induced cytopathic effects. The selectivity 
index (SI) was determined as the ratio of CC50 to EC50. 
4. Conclusions 
SQDG molecules have been isolated for the first time from the red alga Osmundaria obtusiloba and 
their structure elucidated by ESI-MS/MS and 
1H and 
13C NMR analysis, based on HSQC and TOCSY 
fingerprints. MGDG and DGDG have also been identified on the basis of electrospray ionization 
tandem MS/MS spectrometry. We also demonstrated that SGDG had potent antiviral activity against 
HSV-1 and HSV-2 and present low toxicity for cell cultures. Although acyclovir has shown better 
activity, the inhibitory effect in different steps of viral infection is a desirable feature allowing a more 
efficient action and preventing the emergence of resistance strains. The identification of the chemical Mar. Drugs 2012, 10 928 
 
structure of algae glycolipids could contribute for a better understanding of the relation between these 
structures and biological activities. 
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